Blood, Sweat and Epoxy
Speaker
Dr. Arthur Bollon,
Ph.D. - CEO, HemoBio Tech, Inc.
For over 35 years, the
biotech industry has been on a quest to develop a human blood
substitute that would free the medical community from relying on
human blood donations. Many entrepreneurs have tried, and all have
failed for toxicity reasons.
Until now. HemoBio Tech is bringing to market a micro-epoxy of
hemoglobin to remove toxicity, spur blood cell growth, and provide a
replacement for red blood cells.
Come hear Dr. Arthur Bollon, co-founder of HemoBio Tech, describe
this fascinating technology, as well as the sweaty challenges he has
gone through to license, develop and bring it to market. Dr. Bollen
will be a particularly insightful speaker since he is a successful
serial entrepreneur who has co-founded three prior companies and
raised over $80 million in funding, as well as served on the faculty
of Texas Southwestern Medical Center.
Register for the MIT Enterprise Forum
|
Forum date: |
May, 2008 |
| |
|
|
Location: |
UT-Dallas School of
Management building, Executive Dining Room |
| |
|
|
Time: |
6:30 – 7:00 Registration
7:00 – 9:00 Program presentation and discussion |
| |
|
|
Fee: |
Admission with $30 donation
at the door ($20 payment in advance) |
| |
|
To register for this event,
click here or email
mitforum@juno.com.
Coffee and cookies will be provided |
